Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Neuroretinal Rim Area Change in Glaucoma Patients With Visual Field Progression Endpoints and Intraocular Pressure Reduction. The Canadian Glaucoma Study: 4.

Malik R, O'Leary N, Mikelberg FS, Balazsi AG, LeBlanc RP, Lesk MR, Nicolela MT, Trope GE, Chauhan BC; Canadian Glaucoma Study Group.

Am J Ophthalmol. 2016 Mar;163:140-147.e1. doi: 10.1016/j.ajo.2015.11.031. Epub 2015 Dec 17.

PMID:
26705093
2.

Validity, reliability, and repeatability of the useful field of view test in persons with normal vision and patients with glaucoma.

Bentley SA, LeBlanc RP, Nicolela MT, Chauhan BC.

Invest Ophthalmol Vis Sci. 2012 Oct 1;53(11):6763-9. doi: 10.1167/iovs.12-9718.

PMID:
22956614
3.

Rates of change in the visual field and optic disc in patients with distinct patterns of glaucomatous optic disc damage.

Reis AS, Artes PH, Belliveau AC, Leblanc RP, Shuba LM, Chauhan BC, Nicolela MT.

Ophthalmology. 2012 Feb;119(2):294-303. doi: 10.1016/j.ophtha.2011.07.040. Epub 2011 Nov 30.

PMID:
22133797
4.

Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change.

Chauhan BC, Mikelberg FS, Artes PH, Balazsi AG, LeBlanc RP, Lesk MR, Nicolela MT, Trope GE; Canadian Glaucoma Study Group.

Arch Ophthalmol. 2010 Oct;128(10):1249-55. doi: 10.1001/archophthalmol.2010.196. Epub 2010 Aug 9. Erratum in: Arch Ophthalmol. 2010 Dec;128(12):1633.

PMID:
20696979
5.

Optic disc progression in glaucoma: comparison of confocal scanning laser tomography to optic disc photographs in a prospective study.

Chauhan BC, Hutchison DM, Artes PH, Caprioli J, Jonas JB, LeBlanc RP, Nicolela MT.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1682-91. doi: 10.1167/iovs.08-2457. Epub 2008 Dec 5. Erratum in: Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3136.

PMID:
19060290
6.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams.

N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154.

7.

Maraviroc for previously treated patients with R5 HIV-1 infection.

Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams.

N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152.

8.

Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.

Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE; Canadian Glaucoma Study Group.

Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030. Erratum in: Arch Ophthalmol. 2008 Oct;126(10):1364.

PMID:
18695095
9.

Glaucoma and on-road driving performance.

Haymes SA, LeBlanc RP, Nicolela MT, Chiasson LA, Chauhan BC.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3035-41. doi: 10.1167/iovs.07-1609. Epub 2008 Mar 7.

PMID:
18326696
10.

A Canadian glaucoma strategy.

LeBlanc RP; Canadian Glaucoma Strategy Forum.

Can J Ophthalmol. 2007 Feb;42(1):60-5.

PMID:
17361243
11.

Risk of falls and motor vehicle collisions in glaucoma.

Haymes SA, Leblanc RP, Nicolela MT, Chiasson LA, Chauhan BC.

Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1149-55.

PMID:
17325158
12.

Integrated vision care in Nova Scotia: a Canadian model?

Leblanc RP.

Can J Ophthalmol. 2006 Aug;41(4):421-3. No abstract available.

PMID:
16883357
13.

The letter contrast sensitivity test: clinical evaluation of a new design.

Haymes SA, Roberts KF, Cruess AF, Nicolela MT, LeBlanc RP, Ramsey MS, Chauhan BC, Artes PH.

Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2739-45.

PMID:
16723494
14.

Effect of moderate intraocular pressure changes on topographic measurements with confocal scanning laser tomography in patients with glaucoma.

Nicolela MT, Soares AS, Carrillo MM, Chauhan BC, LeBlanc RP, Artes PH.

Arch Ophthalmol. 2006 May;124(5):633-40.

PMID:
16682584
15.

Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study.

Rachlis A, Gill J, Baril JG, LeBlanc RP, Trottier B, MacLeod J, Walmsley S, Van der Vliet W, Belsky G, Burgoyne R.

HIV Clin Trials. 2005 Jul-Aug;6(4):203-12.

PMID:
16323322
16.

Visual field progression in glaucoma: total versus pattern deviation analyses.

Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC.

Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4600-6.

PMID:
16303955
17.

Central corneal thickness and progression of the visual field and optic disc in glaucoma.

Chauhan BC, Hutchison DM, LeBlanc RP, Artes PH, Nicolela MT.

Br J Ophthalmol. 2005 Aug;89(8):1008-12.

18.

Effect of cataract extraction on the visual fields of patients with glaucoma.

Carrillo MM, Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC.

Arch Ophthalmol. 2005 Jul;123(7):929-32.

PMID:
16009833
19.

Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.

Artes PH, Hutchison DM, Nicolela MT, LeBlanc RP, Chauhan BC.

Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2451-7.

PMID:
15980235
20.

Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.

Haymes SA, Hutchison DM, McCormick TA, Varma DK, Nicolela MT, LeBlanc RP, Chauhan BC.

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):547-54.

PMID:
15671281

Supplemental Content

Loading ...
Support Center